London, June 24: Last week, the London Biotechnology Show 2025 wrapped up a dynamic two-day run at ExCeL London, reaffirming its position as one of the most influential gatherings in

London, June 19: Day 1 at the London Biotechnology Show opened to a fantastic start, filled with thought-provoking discussions about crucial topics, groundbreaking innovations on display, a highly engaged community

London, June 17: With just one day to go, the second edition of the London Biotechnology Show (LBS) is set to return to ExCeL London on 18–19 June, uniting

Wahid Awad, Founder and CEO of Rosetta Omics, joined Muhammad Younis for an insightful discussion on the future of precision oncology. He highlighted the challenges of moving beyond standard treatments

United kingdom, On April 23: MHRA Grants Approval to First-Ever UK Treatment for Friedreich’s Ataxia The Medicines and Healthcare products Regulatory Agency (MHRA) has approved omaveloxolone (sold under the

United Kingdom, Apr 21, 2024: A significant advancement in surgical technology has been introduced at HCA Healthcare UK, as London Bridge Hospital becomes the first in the nation to offer

United Kingdom, 11 April 2025: The UK has begun a 12-month rollout of the most significant reform to its clinical trial regulations in over two decades. Signed into law, the

Dr Lestter Cruz Serrano, Head of Global Medical Affairs at Cognizant, joined Muhammad Younis for a thought-provoking session on the transformative role of AI and cloud-based technologies in healthcare. Dr

London, 14 April 2025: Scientists at King’s College London have successfully developed human teeth in the lab using cells derived from patients, potentially enabling adults to regrow lost teeth

LONDON, April 8: As preparations for the second edition of the London Biotechnology Show (LBS25) gather momentum, organisers have announced that registration for the event will be free, a move

The rise of immuno-oncology is transforming cancer treatment, leveraging the body's immune system to combat the disease. In a recent interview, Dr. Alexander Ariel Padrón González, Director of

19 March, 2024: Leeds-based medtech startup, Eventum Orthopaedics, has secured £3.8 million in follow-on investment to expand its groundbreaking surgical device, QuadSense. Designed to enhance knee replacement procedures, QuadSense

13 March, 2025: The University of Liverpool has introduced the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID)—a groundbreaking initiative aimed at improving early detection and treatment of rare eye

10 March 2025: The UK Government has accepted the majority of recommendations from the Regulatory Horizons Council (RHC) regarding the regulation of artificial intelligence (AI) in medical devices, aiming to

Denham, 7 March 2025 – ITK Engineering, a global technology firm and subsidiary of Robert Bosch, is expanding into the UK MedTech sector. With 30 years of expertise in software and